0000902664-21-001476.txt : 20210217 0000902664-21-001476.hdr.sgml : 20210217 20210217214028 ACCESSION NUMBER: 0000902664-21-001476 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210215 FILED AS OF DATE: 20210217 DATE AS OF CHANGE: 20210217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOEL DAVID E. CENTRAL INDEX KEY: 0001548144 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38957 FILM NUMBER: 21647497 MAIL ADDRESS: STREET 1: C/O MATRIX CAPITAL MANAGEMENT CO., LP STREET 2: 1000 WINTER STREET, SUITE 4500 CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Adaptive Biotechnologies Corp CENTRAL INDEX KEY: 0001478320 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 270907024 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1551 EASTLAKE AVENUE EAST SUITE 200 CITY: SEATTLE STATE: WA ZIP: 98102 BUSINESS PHONE: 206-659-0067 MAIL ADDRESS: STREET 1: 1551 EASTLAKE AVENUE EAST SUITE 200 CITY: SEATTLE STATE: WA ZIP: 98102 FORMER COMPANY: FORMER CONFORMED NAME: Adaptive TCR Corp DATE OF NAME CHANGE: 20091209 4 1 ownership.xml X0306 4 2021-02-15 0 0001478320 Adaptive Biotechnologies Corp ADPT 0001548144 GOEL DAVID E. C/O MATRIX CAPITAL MANAGEMENT CO., LP 1000 WINTER STREET, SUITE 4500 WALTHAM MA 02451 1 0 0 0 Common Stock 2021-02-15 4 A 0 1504 0 A 1504 D Stock Option (Right to Buy) 66.5 2021-02-15 4 A 0 3759 0 A 2031-02-15 Common Stock 3759 3759 D The filing of this statement shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. The Reporting Person expressly disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein. The option will vest in equal monthly installments over one year, subject to continued service as a director through such vesting date. /s/ David E. Goel 2021-02-17